Expression of EMMPRIN (CD147) on circulating platelets in vivo.

scientific article published on 7 December 2009

Expression of EMMPRIN (CD147) on circulating platelets in vivo. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1538-7836.2009.03716.X
P698PubMed publication ID19995409
P5875ResearchGate publication ID40482285

P50authorGabrielle PenningsQ48358329
Andy S YongQ56452002
P2093author name stringL Kritharides
P2860cites workAspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometryQ28166510
Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritisQ28191467
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular diseaseQ28195300
Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human plateletsQ28195666
Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheromaQ28214641
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersQ28354193
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Q33183129
Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain.Q33211204
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaquesQ34327535
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with anginaQ40659544
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarctionQ43754686
Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cellsQ45023433
Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by AbciximabQ46480777
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failureQ46547146
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammationQ46728504
Relationship between age and platelet activation in patients with stable and unstable anginaQ46747103
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytesQ46874395
Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromesQ47671940
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.Q51810447
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery diseaseQ58645833
P433issue3
P304page(s)472-481
P577publication date2009-12-07
P1433published inJournal of Thrombosis and HaemostasisQ6296004
P1476titleExpression of EMMPRIN (CD147) on circulating platelets in vivo
P478volume8

Reverse relations

cites work (P2860)
Q36207030Association Study between an SNP in CD147 and Its Expression With Acute Coronary Syndrome in a Jiangsu Chinese Population
Q44894267Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
Q38187226Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases
Q39592493EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall
Q92341061Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
Q50117655Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
Q35152073Function of CD147 in atherosclerosis and atherothrombosis
Q34146011Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.
Q50951282Intravascular blood sampling using the Thrombuster II catheter does not cause artifactual platelet activation.
Q42920120Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications
Q52641024Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.
Q58702065Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma

Search more.